{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T06:05:29Z","timestamp":1780985129773,"version":"3.54.1"},"reference-count":75,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T00:00:00Z","timestamp":1595376000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurolog\u00eda"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.nrl.2020.04.029","type":"journal-article","created":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T04:07:22Z","timestamp":1599624442000},"page":"229-240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Documento de revisi\u00f3n y actualizaci\u00f3n de la cefalea por uso excesivo de medicaci\u00f3n (CUEM)"],"prefix":"10.1016","volume":"36","author":[{"given":"C.","family":"Gonz\u00e1lez-Oria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Belv\u00eds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.L.","family":"Cuadrado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"D\u00edaz-Insa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.L.","family":"Guerrero-Peral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Huerta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Irimia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"L\u00e1inez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Latorre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Leira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Oterino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Porta-Etessam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Pozo-Rosich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"S\u00e1nchez del R\u00edo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Santos-Lasaosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nrl.2020.04.029_bib0380","doi-asserted-by":"crossref","unstructured":"Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders 3.rd edition. Cephalalgia 38 1 2018 1-211.","DOI":"10.1177\/0333102417738202"},{"key":"10.1016\/j.nrl.2020.04.029_bib0385","unstructured":"Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2.nd edition. Cephalalgia. 2004; (Suppl 1):1-160"},{"key":"10.1016\/j.nrl.2020.04.029_bib0390","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/0333102413512033","article-title":"Definitions of medication-overuse headache in population-based studies and their implications on prevalence estimates: A systematic review","volume":"34","author":"Westergaard","year":"2014","journal-title":"Cephalalgia"},{"key":"10.1016\/j.nrl.2020.04.029_bib0395","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1177\/0333102411410082","article-title":"Epidemiology of medication overuse headache in the general Swedish population","volume":"31","author":"Jonsson","year":"2011","journal-title":"Cephalalgia"},{"key":"10.1016\/j.nrl.2020.04.029_bib0400","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1468-2982.2008.01577.x","article-title":"Prevalence of secondary chronic headaches in a population-based sample of 30-44-year-old persons. The Akershus study of chronic headache","volume":"28","author":"Aaseth","year":"2008","journal-title":"Cephalalgia"},{"key":"10.1016\/j.nrl.2020.04.029_bib0405","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1212\/01.WNL.0000120545.45443.93","article-title":"Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life","volume":"62","author":"Col\u00e1s","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2020.04.029_bib0410","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(04)00824-5","article-title":"Medication-overuse headache: a worldwide problem","volume":"3","author":"Diener","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nrl.2020.04.029_bib0415","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s10194-018-0875-x","article-title":"Medication-overuse headache: a widely recognized entity amidst ongoing debate","volume":"19","author":"Vandenbussche","year":"2018","journal-title":"J Headache Pain"},{"key":"10.1016\/j.nrl.2020.04.029_bib0420","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s10194-016-0696-8","article-title":"Risk of medication overuse headache across classes of treatments for acute migraine","volume":"17","author":"Thorlund","year":"2016","journal-title":"J Headache Pain"},{"issue":"Suppl 1","key":"10.1016\/j.nrl.2020.04.029_bib0425","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1007\/s10072-019-03812-8","article-title":"Epidemiology and management of medication-overuse headache in the general population","volume":"40","author":"Russell","year":"2019","journal-title":"Neurol Sci"},{"key":"10.1016\/j.nrl.2020.04.029_bib0430","first-page":"078","volume":"1874","author":"Galli","year":"2019","journal-title":"Personality and personality disorders in medication-overuse headache: a controlled study by SWAP-200. Pain Res Manag"},{"key":"10.1016\/j.nrl.2020.04.029_bib0435","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/ane.13014","article-title":"Multimorbidity in patients with chronic migraine and medication overuse headache","volume":"138","author":"D\u0301Amico","year":"2018","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.nrl.2020.04.029_bib0440","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.pain.2011.08.018","article-title":"Risk factors for medication-overuse headache: an 11-year follow-up study. The Nord-Trondelag Health Studies","volume":"153","author":"Hagen","year":"2012","journal-title":"Pain"},{"key":"10.1016\/j.nrl.2020.04.029_bib0445","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s10194-018-0863-1","article-title":"The role of personality, disability and physical activity in the development of medication-overuse headache: a prospective observational study","volume":"19","author":"Mose","year":"2018","journal-title":"J Headache Pain"},{"key":"10.1016\/j.nrl.2020.04.029_bib0450","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1046\/j.1526-4610.2001.111006303.x","article-title":"Opiate use to control bowel motility may induce chronic daily headache in patients with migraine","volume":"41","author":"Wilkinson","year":"2001","journal-title":"Headache"},{"key":"10.1016\/j.nrl.2020.04.029_bib0455","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1526-4610.2003.03041.x","article-title":"Does chronic daily headache arise de novo in association with regular use of analgesics?","volume":"43","author":"Bahara","year":"2003","journal-title":"Headache"},{"key":"10.1016\/j.nrl.2020.04.029_bib0460","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1526-4610.2008.01257.x","article-title":"Family history for chronic headache and drug overuse as a risk factor for headache chronification","volume":"49","author":"Cevoli","year":"2009","journal-title":"Headache"},{"key":"10.1016\/j.nrl.2020.04.029_bib0465","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.tips.2004.12.008","article-title":"Medication-overuse headache: Similarities with drug addiction","volume":"26","author":"Calabresi","year":"2005","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.nrl.2020.04.029_bib0470","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1468-2982.2004.00789.x","article-title":"Medication overuse headache: Rates and predictors for relapse in a 4-year prospective study","volume":"25","author":"Katsarava","year":"2005","journal-title":"Cephalalgia"},{"key":"10.1016\/j.nrl.2020.04.029_bib0475","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1177\/0333102417728244","article-title":"A systematic review and critical appraisal of gene polymorphism association studies in medication-overuse headache","volume":"38","author":"Cargnin","year":"2018","journal-title":"Cephalalgia"},{"key":"10.1016\/j.nrl.2020.04.029_bib0480","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/0333102410373155","article-title":"Genomic expression patterns in medication overuse headaches","volume":"31","author":"Hershey","year":"2011","journal-title":"Cephalalgia"},{"key":"10.1016\/j.nrl.2020.04.029_bib0485","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S1474-4422(19)30146-2","article-title":"Pathophysiology, prevention, and treatment of medication overuse headache","volume":"18","author":"Diener","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nrl.2020.04.029_bib0490","doi-asserted-by":"crossref","DOI":"10.1097\/ADM.0000000000000504","article-title":"Severity of analgesic dependence and medication-overuse headache","author":"Lundqvist","year":"2019","journal-title":"J Addict Med."},{"key":"10.1016\/j.nrl.2020.04.029_bib0495","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1093\/brain\/awq159","article-title":"Triptan-induced enhancement of neuronal nitric oxide synthase in trigeminal ganglion dural afferents underlies increased responsiveness to potential migraine triggers","volume":"133","author":"De Felice","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.nrl.2020.04.029_bib0500","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1177\/0333102413515344","article-title":"Increased susceptibility to cortical spreading depression in an animal model of medication-overuse headache","volume":"34","author":"Green","year":"2014","journal-title":"Cephalalgia"},{"key":"10.1016\/j.nrl.2020.04.029_bib0505","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1177\/0333102412475235","article-title":"Modulation of central sensitisation by detoxification in MOH: results of a 12-month detoxification study","volume":"33","author":"Munksgaard","year":"2013","journal-title":"Cephalalgia"},{"key":"10.1016\/j.nrl.2020.04.029_bib0510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11916-018-0661-0","article-title":"Neuroimaging findings in patients with medication overuse headache","volume":"16","author":"Lai","year":"2018","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.nrl.2020.04.029_bib0515","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3109\/15622975.2012.665175","article-title":"Grey matter changes associated with medication-overuse headache: Correlations with disease related disability and anxiety","volume":"13","author":"Riederer","year":"2012","journal-title":"World J Biol Psychiatry"},{"key":"10.1016\/j.nrl.2020.04.029_bib0520","doi-asserted-by":"crossref","first-page":"15343","DOI":"10.1523\/JNEUROSCI.3804-12.2013","article-title":"Decrease of grey matter volume in the midbrain is associated with treatment response in medication overuse headache: Possible influence of orbitofrontal cortex","volume":"33","author":"Riederer","year":"2013","journal-title":"J Neurosci"},{"key":"10.1016\/j.nrl.2020.04.029_bib0525","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1177\/0333102413519514","article-title":"Brain functional connectivity and morphology changes in medication-overuse headache clue for dependence-related processes","volume":"34","author":"Chanraud","year":"2014","journal-title":"Cephalalgia"},{"key":"10.1016\/j.nrl.2020.04.029_bib0530","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.nicl.2016.05.007","article-title":"Nucleus accumbens functional connectivity discriminated medication-overuse headache","volume":"11","author":"Torta","year":"2016","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.nrl.2020.04.029_bib0535","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1111\/j.1526-4610.2012.02276.x","article-title":"In medication-overuse headache, fMRI shows long-lasting dysfunction in midbrain areas","volume":"52","author":"Ferraro","year":"2012","journal-title":"Headache"},{"key":"10.1016\/j.nrl.2020.04.029_bib0540","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/brain\/awh691","article-title":"Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine","volume":"129","author":"Fumal","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.nrl.2020.04.029_bib0545","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nrneurol.2016.124","article-title":"Medication-overuse headache: risk factors, pathophysiology and management","volume":"12","author":"Diener","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.nrl.2020.04.029_bib0550","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/head.13230","article-title":"Ergotamine use and overuse in Taiwan: A retrospective cohort study","volume":"58","author":"Chen","year":"2018","journal-title":"Headache."},{"key":"10.1016\/j.nrl.2020.04.029_bib0555","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1046\/j.1468-2982.2000.00067.x","article-title":"The influence of ergotamine abuse on psychological and cognitive functioning","volume":"20","author":"Roon","year":"2000","journal-title":"Cephalalgia"},{"key":"10.1016\/j.nrl.2020.04.029_bib0560","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1161\/01.HYP.28.1.115","article-title":"Reduced distensibility of the common carotid artery in patients treated with ergotamine","volume":"28","author":"Barenbrock","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.nrl.2020.04.029_bib0565","doi-asserted-by":"crossref","unstructured":"Ad Hoc Committee of the International Study Group on Analgesics and Nephropathy. Feinstein AR, Heinemann LA, Curhan GC, Delzell E, Deschepper PJ, Fox JM et al. Relationship between nonphenacetin combined analgesics and nephropathy: a review. Kidney Int. 2000;58:2259 -64","DOI":"10.1046\/j.1523-1755.2000.00410.x"},{"key":"10.1016\/j.nrl.2020.04.029_bib0570","doi-asserted-by":"crossref","unstructured":"Ischemic colitis related to sumatriptan overuse. J Am Borad Fam Med 2010; 23: 124-7.","DOI":"10.3122\/jabfm.2010.01.090086"},{"key":"10.1016\/j.nrl.2020.04.029_bib0575","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1212\/01.wnl.0000183555.54305.fd","article-title":"Chronic daily headache in adolescents: prevalence, impact, and medication overuse","volume":"66","author":"Wang","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2020.04.029_bib0580","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1177\/0883073807307090","article-title":"Emotional problems and prevalence of medication overuse in pediatric chronic daily headache","volume":"22","author":"Pakalnis","year":"2007","journal-title":"J Child Neurol"},{"key":"10.1016\/j.nrl.2020.04.029_bib0585","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1177\/08830738060210011401","article-title":"Medication-overuse headache in children: is initial preventive therapy necessary?","volume":"21","author":"Kossoff","year":"2006","journal-title":"J Child Neurol"},{"key":"10.1016\/j.nrl.2020.04.029_bib0590","unstructured":"AEMPS \u201cUtilizaci\u00f3n de medicamentos opioides en Espan\u00e3 durante el periodo 2008-2015\u201d, 21\/02\/2017. Es una cita de la agencia espa\u00f1ola de medicamentos."},{"key":"10.1016\/j.nrl.2020.04.029_bib0595","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1177\/0333102417736898","article-title":"National awareness campaign to prevent medication-overuse headache in Denmark","volume":"38","author":"Carlsen","year":"2018","journal-title":"Cephalalgia"},{"key":"10.1016\/j.nrl.2020.04.029_bib0600","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1177\/0333102411431309","article-title":"Detoxification for medication overuse is the primary task","volume":"32","author":"Olsen","year":"2012","journal-title":"Cephalalgia"},{"key":"10.1016\/j.nrl.2020.04.029_bib0605","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1468-2982.2006.01175.x","article-title":"Advice alone versus structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs","volume":"26","author":"Rossi","year":"2006","journal-title":"Cephalalgia"},{"key":"10.1016\/j.nrl.2020.04.029_bib0610","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1129-2377-14-10","article-title":"Advice alone versus structured detoxification programmes for complicated medication overuse headache (MOH): a prospective, randomized, open-label trial","volume":"14","author":"Rossi","year":"2013","journal-title":"J Headache Pain"},{"key":"10.1016\/j.nrl.2020.04.029_bib0615","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1468-1331.2010.03094.x","article-title":"Reduction in medication-overuse headache after short information. The Akershus study of chronic headache","volume":"18","author":"Grande","year":"2011","journal-title":"Eur J Neurol."},{"key":"10.1016\/j.nrl.2020.04.029_bib0620","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1468-2982.2007.01326.x","article-title":"Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study","volume":"27","author":"Diener","year":"2007","journal-title":"Cephalalgia"},{"key":"10.1016\/j.nrl.2020.04.029_bib0625","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1526-4610.2006.00684.x","article-title":"Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial","volume":"47","author":"Silberstein","year":"2007","journal-title":"Headache"},{"key":"10.1016\/j.nrl.2020.04.029_bib0630","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1526-4610.2010.01678.x","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program","volume":"50","author":"Dodick","year":"2010","journal-title":"Headache"},{"key":"10.1016\/j.nrl.2020.04.029_bib0635","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jns.2013.05.003","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline","volume":"331","author":"Silberstein","year":"2013","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nrl.2020.04.029_bib0640","doi-asserted-by":"crossref","first-page":"e2309","DOI":"10.1212\/WNL.0000000000007497","article-title":"Erenumab in chronic migraine with medication overuse Subgroup analysis of a randomized trial","volume":"92","author":"Tepper","year":"2019","journal-title":"Neurology"},{"issue":"S2","key":"10.1016\/j.nrl.2020.04.029_bib0645","first-page":"76","article-title":"The impact of fremanezumab on medication overuse in patients with chronic migraine","volume":"58","author":"Silberstein","year":"2018","journal-title":"Headache"},{"key":"10.1016\/j.nrl.2020.04.029_bib0650","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000006640","article-title":"Galcanezumab in chronic migraine: the randomized, double-blind, placebo-controlled REGAIN study","volume":"91","author":"Detke","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2020.04.029_bib0655","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s10194-016-0591-3","article-title":"A two yeas open-label prospective study of OnabotulinumtoxinA 195UI in medication overuse headache: a real-world experience","volume":"17","author":"Negro","year":"2015","journal-title":"J Headache Pain"},{"key":"10.1016\/j.nrl.2020.04.029_bib0660","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/brain\/awz052","article-title":"Acute withdrawal and botulinum toxin A in chronic migraine with medication overuse: a double-blind randomized controlled trial","volume":"142","author":"Pijpers","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.nrl.2020.04.029_bib0665","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/0333102415593088","article-title":"Treatment of medication-overuse headache: A systematic review","volume":"36","author":"Chiang","year":"2016","journal-title":"Cephalalgia"},{"key":"10.1016\/j.nrl.2020.04.029_bib0670","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1468-2982.2008.01711.x","article-title":"Management of medication overuse headache: 1-year randomized multicentre open-label trial","volume":"29","author":"Hagen","year":"2009","journal-title":"Cephalalgia"},{"key":"10.1016\/j.nrl.2020.04.029_bib0675","unstructured":"Leira Mui\u00f1o, R., Dominguez, C., G\u00f3mez Gallego, M., Garrido Robres, J.A., Sanahuja, J., Cefaleas secundarias (I). En: Gu\u00eda\u00a0oficial de pr\u00e1ctica cl\u00ednica\u00a0en cefaleas. Gu\u00edas\u00a0diagn\u00f3sticas y terap\u00e9uticas de la Sociedad Espa\u00f1ola de Neurolog\u00eda\u00a02015. En: Ezpeleta D, Pozo-Rosich P, eds. Madrid: Luzan S.A 2015; 183-204"},{"key":"10.1016\/j.nrl.2020.04.029_bib0680","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1212\/WNL.57.9.1694","article-title":"Clinical features of withdrawal headache following overuse of triptans and other headache drugs","volume":"57","author":"Katsarava","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2020.04.029_bib0685","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1468-1331.2011.03497.x","article-title":"European Federation of Neurological Societies Treatment of medication overuse headache-guideline of the EFNS headache panel","volume":"18","author":"Evers","year":"2011","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nrl.2020.04.029_bib0690","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1468-2982.2000.00028.x","article-title":"Prednisone as initial treatment of analgesic-induced daily headache","volume":"20","author":"Krymchantowski","year":"2000","journal-title":"Cephalalgia"},{"key":"10.1016\/j.nrl.2020.04.029_bib0695","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1046\/j.1468-2982.2003.00648.x","article-title":"Out-patient detoxification in chronic migraine: comparison of strategies","volume":"23","author":"Krymchantowski","year":"2003","journal-title":"Cephalalgia"},{"key":"10.1016\/j.nrl.2020.04.029_bib0700","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1468-2982.2007.01488.x","article-title":"Prednisone versus placebo in withdrawal therapy following medication overuse headache","volume":"28","author":"Pageler","year":"2007","journal-title":"Cephalalgia"},{"key":"10.1016\/j.nrl.2020.04.029_bib0705","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1212\/01.wnl.0000263652.46222.e8","article-title":"Prednisolone does not reduce withdrawal headache: a randomized, double-blind study","volume":"69","author":"B\u00f8e","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.nrl.2020.04.029_bib0710","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jpain.2016.12.005","article-title":"The effectiveness of treatments for patients with medication overuse headache: Systematic Review and Meta-Analysis","volume":"18","author":"De Goffau","year":"2017","journal-title":"J Pain"},{"key":"10.1016\/j.nrl.2020.04.029_bib0715","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1046\/j.1526-4610.2000.00126.x","article-title":"Repetitive intravenous prochlorperazine treatment of patients with refractory chronic daily headache","volume":"40","author":"Lu","year":"2000","journal-title":"Headache"},{"key":"10.1016\/j.nrl.2020.04.029_bib0720","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1046\/j.1526-4610.2002.02127.x","article-title":"Intravenous valproate sodium in the treatment of daily headache","volume":"42","author":"Schwartz","year":"2002","journal-title":"Headache"},{"key":"10.1016\/j.nrl.2020.04.029_bib0725","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1526-4610.1987.hed2703130.x","article-title":"Amelioration of ergotamine withdrawal symptoms with naproxen","volume":"27","author":"Mathew","year":"1987","journal-title":"Headache."},{"key":"10.1016\/j.nrl.2020.04.029_bib0730","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1526-4610.1991.hed3104205.x","article-title":"Subcutaneous sumatriptan in the treatment of headache during withdrawal from drug-induced headache","volume":"31","author":"Diener","year":"1991","journal-title":"Headache"},{"key":"10.1016\/j.nrl.2020.04.029_bib0735","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1046\/j.1526-4610.1998.3809687.x","article-title":"Daily sumatriptan for detoxification from rebound","volume":"38","author":"Drucker","year":"1998","journal-title":"Headache"},{"key":"10.1016\/j.nrl.2020.04.029_bib0740","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/j.1526-4610.2010.01631.x","article-title":"Medication overuse headache: withdrawal and prophylactic therapeutic regimen","volume":"50","author":"Trucco","year":"2010","journal-title":"Headache"},{"key":"10.1016\/j.nrl.2020.04.029_bib0745","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1046\/j.1468-2982.1996.1603197.x","article-title":"Amitriptyline and dexamethasone combined treatment in drug-induced headache","volume":"16","author":"Bonuccelli","year":"1996","journal-title":"Cephalalgia"},{"key":"10.1016\/j.nrl.2020.04.029_bib0750","first-page":"162","article-title":"Efficacy of clomipramine during the weaning period in drug abuse headaches: a blinded study","volume":"II","author":"Lenarduzzi","year":"1988","journal-title":"New Trends in Clin. Neuropharm"}],"container-title":["Neurolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213485320302218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213485320302218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:12:23Z","timestamp":1759324343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213485320302218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0213485320302218"],"URL":"https:\/\/doi.org\/10.1016\/j.nrl.2020.04.029","relation":{},"ISSN":["0213-4853"],"issn-type":[{"value":"0213-4853","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Documento de revisi\u00f3n y actualizaci\u00f3n de la cefalea por uso excesivo de medicaci\u00f3n (CUEM)","name":"articletitle","label":"Article Title"},{"value":"Neurolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nrl.2020.04.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Sociedad Espa\u00f1ola de Neurolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}